MD (MD)
MediData (MD) holds at NEUTRAL due to inconclusive valuation data and a volatility profile that offers no clear directional edge.
- Valuation metrics are entirely absent — no P/E, P/B, or P/S data are available, meaning the stock cannot be priced on fundamentals.
- Implied volatility rank is neutral at 57.0%, providing neither a compelling premium-selling opportunity nor a clear signal of undervaluation.
- The floor analysis concludes the stock is unsuitable for income-oriented strategies, with zero valid floor estimates and a low-confidence discount metric.
BUY-ZONE DECISION rule signal
Sign in
RULES & ALERTS FIRING
Sign in
VALUATION
Floor Engine
YOUR WATCHLIST CONTEXT
○ anonymous· Your personal floor / golden price overlay on the live price
· Per-ticker rule alerts when this stock crosses your thresholds
· Position P&L overlay — what this ticker means inside your full portfolio
IMPLIED VOLATILITY
Earnings Reactions
| Date | Time | EPS | Surprise | Gap% | Day% | Week% |
|---|---|---|---|---|---|---|
| 2026-05-05 | BMO | 0.44 | +16.1% | -6.34% | -7.05% | +5.67% |
| 2026-02-19 | BMO | 0.50 | -7.1% | -14.20% | -12.15% | -9.60% |
| 2025-11-03 | BMO | 0.67 | +43.9% | +15.03% | +24.22% | +33.00% |
| 2025-08-05 | BMO | 0.53 | +24.9% | +10.33% | +5.04% | +19.67% |
| 2025-05-06 | BMO | 0.33 | +36.7% | +2.47% | +11.81% | +11.35% |
| 2025-02-20 | BMO | 0.51 | +39.9% | +4.89% | +22.11% | +6.73% |
| 2024-11-01 | BMO | 0.44 | +19.7% | +12.01% | +23.46% | +27.92% |
| 2024-08-06 | BMO | 0.34 | +11.1% | +9.19% | +17.72% | +32.68% |
Is MD (MD) overvalued right now?
Whether MD (MD) is overvalued depends on the lens you use: trailing P/E vs its own history, CAPE vs the broader market, earnings yield vs Treasury yields. We surface all three so you don't have to pick one in isolation.
MD (MD) — what's the SELL PUT risk profile?
Selling cash-secured puts on MD (MD) is a common income strategy, but the right strike depends on your floor price (the level you'd happily own at) and the option chain's buffer/APY tradeoff. The full ladder view (deferred to a future release) ranks candidates by buffer percentage first, then APY — see the option ladder methodology for why buffer matters more than yield in this strategy.
MD (MD) — which option strategy fits your view?
If you're bullish long-term but cautious near-term on MD (MD), SELL PUT into your floor zone collects premium while waiting for a better entry. If you already own it and are neutral-to-mildly-bullish, COVERED CALL caps upside but harvests time decay. The wrong strategy on the right ticker still loses money — match the trade to your view, not the other way around.
MD (MD) — is now a good entry?
Entry timing on MD (MD) is a function of your floor price (hard buy zone) and golden price (back-the-truck-up zone). Both are personal — set them in your watchlist and we'll alert you when the market hits either level.
FAQ
Why does MD show different P/E numbers on different sites?
Different data providers use different earnings windows (TTM vs forward, GAAP vs adjusted) and update at different cadences. We surface trailing P/E with a 5-year percentile rank to give context — a P/E of 30 is hot for one stock and cold for another.
Does this page show MD's implied volatility?
Not on this v0 page — the dedicated volatility tool covers IV with multi-source voting (IBKR + Polygon + yfinance). For pure IV lookup, use /tools/volatility. This page is for decision-stage queries that pull together valuation + portfolio context.
How is this different from Yahoo Finance or 雪球's MD page?
Those sites are great for raw data discovery — last price, news, headline P/E. This page is built for the second look: you've already seen a single-dimension signal somewhere else, now you need multi-dimensional decision context (your floor, the valuation percentile, your portfolio overlay) in one view, not five tabs.